BUEMI, MARIAROSA
 Distribuzione geografica
Continente #
EU - Europa 2.070
NA - Nord America 1.773
AS - Asia 1.063
SA - Sud America 305
AF - Africa 32
Totale 5.243
Nazione #
US - Stati Uniti d'America 1.745
RU - Federazione Russa 1.133
SG - Singapore 415
CN - Cina 361
BR - Brasile 267
IE - Irlanda 256
SE - Svezia 233
IT - Italia 147
HK - Hong Kong 118
FR - Francia 66
DE - Germania 52
VN - Vietnam 48
GB - Regno Unito 46
FI - Finlandia 39
IN - India 39
UA - Ucraina 22
BE - Belgio 21
AR - Argentina 16
MX - Messico 13
ZA - Sudafrica 13
IQ - Iraq 12
CA - Canada 11
MA - Marocco 11
BD - Bangladesh 10
CZ - Repubblica Ceca 10
PL - Polonia 10
TR - Turchia 10
EC - Ecuador 8
JP - Giappone 7
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
ID - Indonesia 5
NL - Olanda 5
CL - Cile 4
ES - Italia 4
MY - Malesia 4
AT - Austria 3
CH - Svizzera 3
GR - Grecia 3
JO - Giordania 3
LK - Sri Lanka 3
LU - Lussemburgo 3
PK - Pakistan 3
PY - Paraguay 3
RO - Romania 3
UZ - Uzbekistan 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
LV - Lettonia 2
NO - Norvegia 2
PE - Perù 2
TN - Tunisia 2
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KR - Corea 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UY - Uruguay 1
VE - Venezuela 1
Totale 5.243
Città #
Moscow 334
Ashburn 309
Dublin 256
Singapore 227
Dallas 196
Chandler 190
Nyköping 168
Beijing 131
Hong Kong 117
Ann Arbor 75
Jacksonville 70
Messina 70
San Jose 70
The Dalles 58
Los Angeles 46
Princeton 40
Lauterbourg 36
Medford 36
Cambridge 33
Des Moines 26
Dearborn 23
Jinan 23
New York 21
Boardman 20
Brussels 19
Hyderabad 16
Orem 16
São Paulo 16
Guangzhou 15
Munich 15
Tianjin 15
Redondo Beach 14
San Mateo 14
Shenyang 14
Wilmington 14
Buffalo 13
Denver 12
Catania 11
Ho Chi Minh City 11
Ningbo 11
Rio de Janeiro 11
Santa Clara 11
Seattle 11
Woodbridge 11
Francofonte 10
Johannesburg 10
Frankfurt am Main 9
Taizhou 9
Belo Horizonte 8
Brasília 8
Brno 8
Brooklyn 8
Fuzhou 8
Haikou 8
Phoenix 8
Hangzhou 7
Hanoi 7
Houston 7
London 7
Pune 7
Boston 6
Chicago 6
Düsseldorf 6
Hebei 6
Jiaxing 6
Montreal 6
Turku 6
Warsaw 6
Baghdad 5
Guayaquil 5
Helsinki 5
Lancaster 5
Nanjing 5
Porto Alegre 5
Shanghai 5
Tokyo 5
Zhengzhou 5
Agadir 4
Bexley 4
Biên Hòa 4
Council Bluffs 4
Helena 4
Manchester 4
Mexico City 4
Nanchang 4
Nova Iguaçu 4
Nuremberg 4
Riyadh 4
Rome 4
Salvador 4
Washington 4
Amman 3
Athens 3
Atlanta 3
Clearwater 3
Colombo 3
Dhaka 3
Guarulhos 3
Istanbul 3
Kuala Lumpur 3
Totale 3.150
Nome #
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 256
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 203
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 198
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 188
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 182
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 181
Discovery of a new potent inhibitor of mushroom tyrosinase (Agaricus bisporus) containing 4-(4-hydroxyphenyl)piperazin-1-yl moiety 181
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 179
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 179
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 161
Graphene Quantum Dots Based Systems As HIV Inhibitors 161
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 153
From NMDA receptor antagonists to discovery of selective σ2 receptor ligands 152
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 144
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 143
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 139
Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase 135
Structural optimization of N1-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 135
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 133
Probing Molecular Interactions between Human Carbonic Anhydrases (hCAs) and a Novel Class of Benzenesulfonamides 133
Searching for novel N1-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors 131
Design, Synthesis and Biostructural Characterization of Carbonic Anhydrase Inhibitors 129
Rational design, synthesis and evaluation of coumarin derivatives as protein-protein interaction inhibitors 129
Synthesis and biological characterization of novel potent arylsulfonamides as human carbonic anhydrase inhibitors (hCAIs) targeting central nervous system 126
Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: Synthesis, biological evaluation, and molecular modeling studies 124
Identification of 3-substituted-1H-indoles as ligands of GluN2B containing N-methyl-D-aspartate receptors 122
Searching for NR2B/NMDA Receptor Antagonists As Neuroprotective Agents 121
Inhibition of HIV-1 RT activity by a new series of 3-(1,3,4-thiadiazol-2-yl)thiazolidin-4-one derivatives 120
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 115
Identification of influenza PA-Nter endonuclease inhibitors using pharmacophore- and docking-based virtual screening 112
Synthesis and Biological Characterization of 3-Substituted-1H-indoles as Ligands of GluN2B-Containing N-Methyl-d-aspartate Receptors 104
Progettazione e sintesi di antagonisti non competitivi del recettore NR2B/NMDA 100
Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-d-aspartate receptor (NMDAR) containing GluN2B subunit 93
Synthesis, Modelling and Biological Characterization of 3-Substituted-1H-indoles as Ligands of GluN2B-containing N-Methyl-d-Aspartate Receptors 89
SYNTHESIS AND BIOLOGICAL CHARACTERIZATION OF NEW NR2B/NMDA RECEPTOR LIGANDS 87
SYNTHESIS AND BIOLOGICAL CHARACTERIZATION OF 3-SUBSTITUTED-1H-INDOLES AS LIGANDS OF GLUN2B-CONTAINING N-METHYL-D-ASPARTATE RECEPTORS 82
Synthesis and Biological Characterization of 3-Substituted-1H-indoles as Ligands of GluN2B-containing N-Methyl-D-Aspartate Receptors. Part. 2. 79
Rational Design and synthesis of new GluN2B/NMDA receptor ligands as neuroprotective agents. 76
Targeting GluN2B-containing N-Methyl-D-aspartate receptors: design, synthesis, and binding affinity evaluation of novel 3-substituted indoles. 76
Totale 5.351
Categoria #
all - tutte 16.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.757


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/2022341 4 54 2 19 1 1 46 16 5 8 106 79
2022/2023730 46 65 33 75 57 61 14 30 328 2 16 3
2023/2024188 11 25 9 48 11 44 0 8 0 17 0 15
2024/2025752 15 8 15 45 42 14 12 164 182 52 81 122
2025/20262.606 109 207 156 214 237 585 283 319 306 115 29 46
Totale 5.351